08:00 , Feb 6, 2012 |  BC Week In Review  |  Company News

Aurum Biosciences, Oxygen Biotherapeutics deal

The companies partnered to develop a diagnostic and therapeutic to treat acute ischemic stroke using Oxygen's Oxycyte perfluorocarbon (PFC)-based therapeutic oxygen carrier in combination with Aurum's Glasgow Oxygen Level Dependent (GOLD) MRI techniques. The partners...
07:00 , Sep 26, 2011 |  BC Week In Review  |  Company News

Aurum Biosciences Ltd., Oxygen Biotherapeutics deal

Oxygen disclosed in its 1Q12 earnings ended July 31 that in July it signed a letter of intent with Aurum to conduct preclinical research evaluating Oxygen's Oxycyte perfluorocarbon (PFC)-based therapeutic oxygen carrier in combination with...